Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemotherapy Combined With Cytokine-induced Killer in Colon Cancer
NCT03084809Phase 4Completed
- Sponsor
- Emergency General Hospital
- Start
- May 2012
- Primary completion
- Sep 2014
- Modality
- Allogeneic CAR-T, Tumor-Infiltrating Lymphocytes (TILs), TCR-Engineered T Cells
01
Overview
A Phase 4 trial of unmodified CIK in colorectal cancer (CRC), sponsored by Emergency General Hospital. Started May 2012; status: completed.
02
Drugs
unmodified CIK
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT03084809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03084809.